Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
B338598-5mg | 5mg | In stock | $75.90 | |
B338598-10mg | 10mg | In stock | $129.90 | |
B338598-50mg | 50mg | In stock | $271.90 | |
B338598-100mg | 100mg | In stock | $489.90 | |
B338598-500mg | 500mg | In stock | $14,586.90 |
a Jun kinase (JNK) inhibitor
Synonyms | Bentamapimod | 848344-36-5 | AS 602801 | AS-602801 | AS602801 | Bentamapimod (Tautomer) | PGL5001 | Bentamapimod [INN] | PGL-5001 | TT3L4B4U0N | 2-(1,3-benzothiazol-2-yl)-2-[2-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]pyrimidin-4-yl]acetonitrile | 541507-14-6 | 2-(Benzo[d]thiazol |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | AS602801 (Bentamapimod, PGL5001) is an orally active, ATP-competitive, potent and selective c-Jun N-terminal kinase (JNK) inhibitor (JNK1/2/3 IC50 = 80/90/230 nM). AS602801 decreases MMP-3 upregulation in endometrium cultures from patients with endometrio |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | c-Jun N-terminal kinase, JNK inhibitor |
Product Description | Bentamapimod is a selective JNK (Jun kinase) inhibitor that has been found to be active via oral administration. The small molecule blocks T-cell proliferation and induces apoptosis. |
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Pubchem Sid | 488196575 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488196575 |
IUPAC Name | 2-(1,3-benzothiazol-2-yl)-2-[2-[[4-(morpholin-4-ylmethyl)phenyl]methoxy]pyrimidin-4-yl]acetonitrile |
INCHI | InChI=1S/C25H23N5O2S/c26-15-20(24-28-22-3-1-2-4-23(22)33-24)21-9-10-27-25(29-21)32-17-19-7-5-18(6-8-19)16-30-11-13-31-14-12-30/h1-10,20H,11-14,16-17H2 |
InChi Key | XCPPIJCBCWUBNT-UHFFFAOYSA-N |
Canonical SMILES | C1COCCN1CC2=CC=C(C=C2)COC3=NC=CC(=N3)C(C#N)C4=NC5=CC=CC=C5S4 |
Isomeric SMILES | C1COCCN1CC2=CC=C(C=C2)COC3=NC=CC(=N3)C(C#N)C4=NC5=CC=CC=C5S4 |
PubChem CID | 10195250 |
Molecular Weight | 457.55 |
ChEMBL Ligand | CHEMBL3545213 |
---|---|
PubChem CID | 10195250 |
CAS Registry No. | 848344-36-5 |
PubChem SID | 488196575 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
E2318263 | Certificate of Analysis | Apr 04, 2023 | B338598 |
E2318265 | Certificate of Analysis | Apr 04, 2023 | B338598 |
E2318267 | Certificate of Analysis | Apr 04, 2023 | B338598 |
E2318268 | Certificate of Analysis | Apr 04, 2023 | B338598 |
E2318270 | Certificate of Analysis | Apr 04, 2023 | B338598 |
E2318273 | Certificate of Analysis | Apr 04, 2023 | B338598 |
E2318275 | Certificate of Analysis | Apr 04, 2023 | B338598 |
E2318282 | Certificate of Analysis | Apr 04, 2023 | B338598 |
E2318284 | Certificate of Analysis | Apr 04, 2023 | B338598 |
E2318285 | Certificate of Analysis | Apr 04, 2023 | B338598 |
Solubility | insoluble in H2O; insoluble in EtOH; ≥11.45 mg/mL in DMSO |
---|---|
Refractive Index | n20D1.67 (Predicted) |
Boil Point(°C) | 666.5° C at 760 mmHg (Predicted) |
Pictogram(s) | GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H302:Harmful if swallowed H332:Harmful if inhaled H302+H332:Harmful if swallowed or if inhaled |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P301+P317:IF SWALLOWED: Get medical help. P317:Get emergency medical help. P332+P317:If skin irritation occurs: Get medical help. |
1. Hussein M, Chai DC, Kyama CM, Mwenda JM, Palmer SS, Gotteland JP, D'Hooghe TM. (2016) c-Jun NH2-terminal kinase inhibitor bentamapimod reduces induced endometriosis in baboons: an assessor-blind placebo-controlled randomized study.. Fertil Steril, 105 (3): (815-824.e5). [PMID:26654972] |
2. Okada M, Kuramoto K, Takeda H, Watarai H, Sakaki H, Seino S, Seino M, Suzuki S, Kitanaka C. (2016) The novel JNK inhibitor AS602801 inhibits cancer stem cells in vitro and in vivo.. Oncotarget, 7 (19): (27021-32). [PMID:27027242] |
3. Palmer SS, Altan M, Denis D, Tos EG, Gotteland JP, Osteen KG, Bruner-Tran KL, Nataraja SG. (2016) Bentamapimod (JNK Inhibitor AS602801) Induces Regression of Endometriotic Lesions in Animal Models.. Reprod Sci, 23 (1): (11-23). [PMID:26335175] |